Political versus epidemiological correctness

Infection Control and Hospital Epidemiology

Volumn 28, Issue 5, 2007, Pages 589-593

  Farr, Barry M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ENTEROCOCCUS; HEALTH CARE; HEALTH CARE ORGANIZATION; HOSPITAL INFECTION; HUMAN; MEDICAL LITERATURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOTE; POLITICS; PRACTICE GUIDELINE;

CROSS INFECTION; DISEASE OUTBREAKS; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; ILLINOIS; INFECTION CONTROL; MARYLAND; MASS SCREENING; METHICILLIN RESISTANCE; POLITICS; POPULATION SURVEILLANCE; PRACTICE GUIDELINES; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 34249690199     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/515710     Document Type: Note

References (58)

1. Weber SG, Huang SS, Oriola S, et al. Legislative mandates for active surveillance cultures for MRSA and VRE: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol 2007; 28:249-260.
2. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24: 362-386. Available at: http://www.shea-online.org/Assets/files/position _papers/ SHEA_MRSA_VRE.pdf. Accessed March 21, 2007.
3. Siegel JD, Rhinehart E, Jackson M, Chiarello L, the Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Available at: http:// www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed November 13, 2006.
4. Illinois General Assembly. Bill Status of SB2771, 94th General Assembly. Available at: http://www.ilga.gov/legislation/BillStatus.asp?GA=94& DocTypeID=SB&DocNum=2771&GAID=8&SessionID=50&8LegID =23855. Accessed January 10, 2007.
5. Illinois General Assembly. Bill Status of SB3087, 94th General Assembly. Available at: http://www.ilga.gov/legislation/billstatus.asp?DocNum= 3087&GAID=8&GA=94&DocTypeID=SB&LegID=24218&SessionID =50. Accessed January 10, 2007.
6. Peterson L. Lessons to be shared in successful reductions of infections. Illinois Quality Leadership Conference - Focusing on Reducing and Eliminating Infections. Naperville, IL: Hospital Association and Metropolitan Chicago Healthcare Council; May 24, 2006.
7. Maryland General Assembly. Hospitals and Nursing Facilities - Healthcare-Associated Infections Prevention and Control Program. Available at: http:// mlis.state.md.us/2006rs/bills/sb/sb0535f.pdf. Accessed March 21, 2007.
8. Farr BM. What to think if results of the NIH randomized trial of MRSA and VRE control is negative (and other advice to young epidemiologists): a review and an au revoir. Infect Control Hosp Epidemiol 2006; 27:1096-1106.
9. Farr BM. Doing the right thing (and figuring out what that is). Infect Control Hosp Epidemiol 2006; 27:999-1003.
10. Jernigan JA, Titus MG, Groschel DH, Getchell-White S, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996; 143:496-504.
11. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Int Med 1982; 97:309-317.
12. Pan A, Carnevale G, Catenazzi P, et al. Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA. Infect Control Hosp Epidemiol 2005; 26:127-133.
13. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001; 344:1427-1433.
14. Kotilainen P, Routamaa M, Peltonen R, et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 2001; 161:859-863.
15. Harberg D. Society for Healthcare Epidemiology of America guideline approach works to control a methicillin-resistant Staphylococcus aureus outbreak. Infect Control Hosp Epidemiol 2005; 26:115-116.
16. Silverblatt FJ, Tibert C, Mikolich D, et al. Preventing the spread of vancomycin-resistant enterococci in a long-term care facility. J Am Geriatr Soc 2000; 48:1211-1215.
17. Dailey L, Coombs GW, O'Brien FG, et al. Methicillin-resistant Staphylococcus aureus, Western Australia. Emerg Infect Dis 2005; 11:1584-1590.
18. Verhoef J, Beaujean D, Blok H, et al. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999; 18: 461-466.
19. Tiemersma EW, Monnet DL, Bruinsma N, Skov R, Monen JC, Grundmann H. Staphylococcus aureus bacteremia, Europe. Emerg Infect Dis 2005; 11:1798-1799.
20. Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-1634.
21. Salgado C, Farr B. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiology cultures? Infect Control Hosp Epidemiol 2006; 27:116-121.
22. Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis 2003; 37:326-332.
23. Strausbaugh LJ, Siegel JD, Weinstein RA. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of two guidelines. Clin Infect Dis 2006; 42:828-835.
24. Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee. Society for Healthcare Epidemiology of America. Association for Professionals in Infection Control. Infectious Diseases Society of America. Hand Hygiene Task Force. Guideline for Hand Hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002; 23(12 suppl):S3-40.
25. Webster J, Faoagali JL, Cartwright D. Elimination of methicillin- resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 1994; 30:59-64.
26. Vriens MR, Fluit AC, Troelstra A, Verhoef J, van der Werken C. Is methicillin-resistant Staphylococcus aureus more contagious than methicillin-susceptible S. aureus in a surgical intensive care unit [erratum appears in Infect Control Hosp Epidemiol 2002; 23:579]. Infect Control Hosp Epidemiol 2002; 23:491-494.
27. Esveld MI, de Boer AS, Notenboom AJ, van Pelt W, van Leeuwen WJ. Secondary infection with methicillin resistant Staphylococcus aureus in Dutch hospitals (July 1997-June 1996). Nederlands Tijdschrift voor Geneeskunde 1999; 143:205-208.
28. Blank M, Haas L, Donahoe M, Kramer P, Muto C. Sustained effect in reducing methicillin-resistant Staphylococcus aureus (MRSA) hospital-acquired infections (HAIs) using active MRSA surveillance cultures (MSC) - three year follow-up. In: Program and abstracts of the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Los Angeles). 2005:64. Abstract 22.
29. Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006; 43:971-978.
30. Verbrugh HA. Best practices from The Netherlands. In: Program and abstracts of the 2nd Infection Prevention and Control Conference: Managing MRSA - A Call To Action. Co-convened by the Association for Professionals in Infection Control and Epidemiology and Joint Commission Resources; August 15, 2006; Cambridge, MA.
31. Calfee DP, Salgado CD, Giannetta ET, Farr BM. Effectiveness of surveillance cultures (SC) and contact precautions (CP) for controlling methicillin-resistant S. aureus (MRSA) and vancomycin- resistant Enterococcus (VRE) in a non-academic community hospital. In: Program and abstracts of the 14th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Philadelphia). 2004:128. Abstract 363.
32. West TE, Guerry C, Hiott M, Morrow N, Ward K, Salgado CD. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 2006; 27:233-238.
33. Jernigan JA, Clemence MA, Stott GA, et al. Control of methicillin resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995; 16:686-696.
34. Farrington M, Redpath C, Trundle C, Coomber S, Brown NM. Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus (MRSA) infection at a teaching hospital. QJM 1998; 91:539-548.
35. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA 2004; 101:3709-3714.
36. Smith DL, Levin SA, Laxminarayan R. Strategic interactions in multiinstitutional epidemics of antibiotic resistance. Proc Natl Acad Sci USA 2005; 102:3153-3158.
37. da Silva Coimbra MV, Silva-Carvalho MC, Wisplinghoff H, et al. Clonal spread of methicillin-resistant Staphylococcus aureus in a large geographic area of the United States. J Hosp Infect 2003; 53:103-110.
38. Vandenbroucke-Grauls CM, Frenay HM, van Klingeren B, Savelkoul TF, Verhoef J. Control of epidemic methicillin-resistant Staphylococcus aureus in a Dutch university hospital. Eur J Clin Microbiol Infect Dis 1991; 10: 6-11.
39. Seeberg S, Larsson L, Welinder-Olsson C, et al. How an outbreak of MRSA in Gothenburg was eliminated: by strict hygienic routines and massive control-culture program. Lakartidningen 2002; 99:3198-3204.
40. Kotilainen P, Routamaa M, Peltonen R, et al. Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis 2003; 9:169-175.
41. Lucet JC, Paoletti X, Lolom I, et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005; 31:1051-1057.
42. Montecalvo MA, Jarvis WR, Uman J, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Int Med 1999; 131:269-272.
43. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003; 290:1899-1905.
44. Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995; 171:614-624.
45. Muto CA, Giannetta ET, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002; 23: 429-435.
46. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002; 51:126-132.
47. Vernon M, Haydem M, Trick W, et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit. Arch Intern Med 2006; 166: 306-312.
48. Beck-Sague CM, Dooley SW, Hutton MD, et al. Outbreak of multidrug-resistant tuberculosis among persons with HIV infection in an urban hospital: transmission to staff and patients and control measures. JAMA 1992; 268:1280-1286.
49. Clancy M, Graepler A, Wilson M, Douglas I, Johnson J, Price CS. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 2006; 27:1009-1017.
50. Urth T, Juul G, Skov R, Schonheyder HC. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol 2005; 26:144-149.
51. Rubin Z, Edwards JR, Horan TS, Jernigan JA. Staphylococcal surgical site infection following coronary artery bypass and joint replacement surgery, National Nosocomial Infections Surveillance System, 1994-2003. In: Program and abstracts of the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Los Angeles). 2005. Abstract 42.
52. Muto CA, Blank MK, Pokrywka M, et al. Reduction of methicillin-resistant Staphylococcus aureus (MRSA) hospital acquired infections in a medical ICU: effect of a MRSA control initiative during a concurrent central line associated BSI reduction initiative. In: Program and abstracts of the 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Chicago). 2006:86. Abstract 67.
53. Klevens R, Edwards J, Tenover F, McDonald L, Horan T, Gaynes R. National Nosocomial Infections Surveillance System. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006; 42:389-391.
54. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
55. Strausbaugh LJ, Jacobson C, Yost T. Methicillin-resistant Staphylococcus aureus in a nursing home and affiliated hospital: a 4-year perspective. Infect Control Hosp Epidemiol 1993; 14:331-336.
56. Hartstein AI. Improved understanding and control of nosocomial methicillin-resistant Staphylococcus aureus: are we overdoing it? Infect Control Hosp Epidemiol 1995; 16:257-259.
57. Barrett SP, Mummery RV, Chattopadhyay B. Trying to control MRSA causes more problems than it solves. J Hosp Infect 1998; 39:85-93.
58. Farr BM, Weinstein RA. Controlling VRE and MRSA: standard precautions vs. surveillance cultures and contact precautions. In: Program and abstracts of the 40th Annual Meeting of the Infectious Diseases Society of America (Chicago). 2002: 6 (addendum). Abstract S10.